The Orphan Drug Imperative: Exploring Regulatory Incentives and...

agregó una foto Health

2025-11-04 09:07:55 -

The Orphan Drug Imperative: Exploring Regulatory Incentives and Investment Trends Fueling the Rare Disease Segment

The rare disease segment, predominantly served by **orphan drugs**—medications developed to treat conditions affecting a very small patient population—has become a disproportionately powerful engine of innovation and investment within the specialty pharmaceuticals market. This growth is largely fueled by significant **regulatory incentives**, most notably the U.S. Orphan Drug Act...

0 Commentarios 0 Acciones 422 Views 0 Vista previa